These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22134146)

  • 1. Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana.
    Ramogola-Masire D; de Klerk R; Monare B; Ratshaa B; Friedman HM; Zetola NM
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):308-13. PubMed ID: 22134146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.
    Parham GP; Mwanahamuntu MH; Kapambwe S; Muwonge R; Bateman AC; Blevins M; Chibwesha CJ; Pfaendler KS; Mudenda V; Shibemba AL; Chisele S; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Chi BH; Stringer JS; Sankaranarayanan R; Sahasrabuddhe VV
    PLoS One; 2015; 10(4):e0122169. PubMed ID: 25885821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
    Pfaff C; Singano V; Akello H; Amberbir A; Berman J; Kwekwesa A; Matengeni A; Banda V; Msonko J; Speight C; Kabeya BM; van Oosterhout JJ
    Malawi Med J; 2018 Sep; 30(3):211-214. PubMed ID: 30627358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.
    Pfaendler KS; Mwanahamuntu MH; Sahasrabuddhe VV; Mudenda V; Stringer JS; Parham GP
    Gynecol Oncol; 2008 Sep; 110(3):402-7. PubMed ID: 18556050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
    Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
    JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.
    Ramogola-Masire D; McGrath CM; Barnhart KT; Friedman HM; Zetola NM
    Int J Gynecol Pathol; 2011 Nov; 30(6):591-6. PubMed ID: 21979597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of human papillomavirus video education for women participating in mass cervical cancer screening in Tanzania.
    Cooper EC; Maher JA; Naaseh A; Crawford EW; Chinn JO; Runge AS; Lucas AN; Zezoff DC; Bera KR; Dinicu AI; White KM; Tewari SE; Hari A; Bernstein M; Chang J; Ziogas A; Pearre DC; Tewari KS
    Am J Obstet Gynecol; 2021 Jan; 224(1):105.e1-105.e9. PubMed ID: 32682861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 9. A systematic review of the effects of visual inspection with acetic acid, cryotherapy, and loop electrosurgical excision procedures for cervical dysplasia in HIV-infected women in low- and middle-income countries.
    Forhan SE; Godfrey CC; Watts DH; Langley CL
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S350-6. PubMed ID: 25768874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
    Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
    J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of visual inspection with acetic acid plus cryotherapy "see and treat" approach on the reduction of the population burden of cervical preinvasive lesions in Southeast Nigeria.
    Chigbu CO; Onyebuchi AK; Nnakenyi EF; Egbuji CC
    Niger J Clin Pract; 2017 Feb; 20(2):239-243. PubMed ID: 28091444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial.
    Firnhaber C; Swarts A; Goeieman B; Rakhombe N; Mulongo M; Williamson AL; Michelow P; Ramotshela S; Faesen M; Levin S; Wilkin T
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):532-538. PubMed ID: 28902073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
    Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
    Oncologist; 2013; 18 Suppl():6-12. PubMed ID: 24334477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
    Kuhn L; Wang C; Tsai WY; Wright TC; Denny L
    AIDS; 2010 Oct; 24(16):2553-61. PubMed ID: 20706107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
    Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
    Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
    Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
    BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of cervical neoplasia in HIV-infected women in India.
    Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
    AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
    Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R
    BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Cervical Cancer Screening Techniques in HIV-Infected Women in Uganda.
    Bansil P; Lim J; Byamugisha J; Kumakech E; Nakisige C; Jeronimo JA
    J Low Genit Tract Dis; 2015 Jul; 19(3):215-9. PubMed ID: 25551591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.